Beta Drugs IPO Details

Issue Open Sep 29, 2017
Issue Close Oct 4, 2017
IPO Price ₹85
Face Value ₹10
IPO Size ₹19.52 Cr
Listing At NSE SME
IPO Lot Size 1600
  1. Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells

    Wed, 31 Mar 2021 05:19:00 GMT

    The proceeds of the IPO will be used to drive the development of the company’s pipeline of bispecific antibody drugs, which are designed to treat ... immuno-oncology therapies is cancer-busting alpha ...

  2. Defiance ETFs: A Revolution In Thematic ETF Investing (Podcast Transcript)

    Mon, 29 Mar 2021 01:23:00 GMT

    The rise in thematic ETFs in 2020 was remarkable, with assets increasing by 78% in Q4 alone, to $104B in AUM. This meteoric growth has been powered by firms like Defiance, a relative newcomer to the ...

  3. Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic

    Mon, 22 Mar 2021 17:00:00 GMT

    TGF-beta signaling pathways ... In its prospectus, Keros said it would use the IPO cash to support its pipeline through clinical trials. The company’s lead drug candidate, KER-050, is a ...

  4. Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO

    Thu, 11 Mar 2021 16:00:00 GMT

    But Imara has its IPO cash and it will continue its research on drugs for rare blood conditions ... one in in sickle cell disease and the other in beta thalassemia, another rare blood disorder.

  5. Dorsey, Saul Ewing Steer Pot Co. Ascends $125M IPO

    Mon, 29 Mar 2021 16:31:00 GMT

    "If that occurs, we may be deemed to be producing, cultivating or dispensing cannabis and drug paraphernalia in violation of federal law." Dorsey & Whitney LLP provided legal counsel for matters ...

  6. The Promises Behind Terns Multi-Pronged Pipeline

    Fri, 26 Mar 2021 05:03:00 GMT

    From its IPO price of $17 per share ... is a thyroid hormone receptor-beta agonist currently in phase 1 trials. Again, similar drugs have been troublesome in the past (specifically, toxic to ...

  7. Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update

    Thu, 25 Mar 2021 05:00:00 GMT

    Recent Business Highlights Addition to Russell 2000 Index: On March 22, 2021, Sensei was added to the Russell 2000® Index as part of its quarterly IPO additions. The Russell 2000® Index is a ...

  8. South Korea’s SK Group Makes Biotech Push With $1.3 Billion IPO Of Covid Vaccine Unit

    Tue, 16 Mar 2021 17:00:00 GMT

    SK Bioscience, which produces Covid-19 vaccines in Korea, could raise up to $1.33 billion, which would be the biggest Korea IPO since 2017 ... Its contract drug-manufacturing arm Samsung ...

  9. Compass IPO debut: Heres how the stock is doing

    Thu, 01 Apr 2021 09:28:00 GMT

    Shares opened at $21.25 popping as much as 22% in the first few minutes of trading. Compass priced its IPO at $18 a share, at the low end of its reduced range. The company raised $480 million dollars ...

  10. Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update

    Thu, 25 Mar 2021 05:09:00 GMT

    Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net -Successfully completed upsized IPO in February 2021 ... an investigational new drug (IND) application with the U.S ...

Beta Drugs IPO Alerts

1. Beta Drugs Limited IPO - Close  Wednesday, September 27, 2017 10:39:31 AM

The issue of Beta Drugs Limited opens on Sep 29, 2017 and closes for subscription on Oct 04, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 85.

2. Beta Drugs Limited IPO - Open  Wednesday, September 27, 2017 10:39:12 AM

Beta Drugs Limited is entering in the capital market with an IPO of 229,600 Equity Shares of Rs 10 aggregating up to Rs 1.95 Cr. The price band for the issue has been fixed at Rs 85.

Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.

The issue opens on Sep 29, 2017 and closes for subscription on Oct 4, 2017. The equity shares of the company to be list at NSE SME platform.

Beta Drugs IPO News & Events FAQs

  1. 1. When Beta Drugs IPO expected date?

    The Beta Drugs IPO is proposed to open on Sep 29, 2017. The IPO application ends on Oct 4, 2017.

  2. 2. How to purchase Beta Drugs IPO?

    Retail investors can apply in the retail or non-institutional investor category from Sep 29, 2017 to Oct 4, 2017. The Beta Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Beta Drugs IPO will come?

    The Beta Drugs IPO will open for subscription on Sep 29, 2017. The public issue will close on Oct 4, 2017.


Comments

   I Like It. | Report Abuse








Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App